High levels of intact IGFBP-3 and some IGFBP-3 fragments could be associated with reduced breast cancer risk, whereas high levels of total IGFBP-3 could be associated with increased breast cancer risk [37, 38]. The gene discussed is IGFBP3; the disease is breast cancer.